14 -15
May

Venture Capital & Private Equity

Investment Challenges and Opportunities in Emerging Biotech Markets

Hyatt Regency Princeton

What to expect

Timely information, interactive format

Real insights are shared in conversations, not lectures. That’s why our unique roundtable format guarantees real learning and ensures you only attend discussions that deliver value to you.

Join as many as four roundtable discussions, each with up to 20 other subject experts, networking with top-level peers in an informal, relaxed and sociable environment.

Meet Our Facilitators

Our panel of facilitators plays a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at the Venture Capital & Private Equity.

Alex Zisson

Managing Director H.I.G. Capital

Allan Gobbs

Co-Founder & Managing Partner ATEM Capital

Arnold Lippa

Executive Chairman, Chief Executive Officer and Chief Scientific Officer RespireRx Pharmaceuticals Inc.

Ashok Srivastava

Chief Clinical Officer Autolus Therapeutics

Heather Rose

Vice President of Technology Licensing and Start-Ups Thomas Jefferson Health

Mark Tornetta

VP/Director of Biologics Discovery Tavotek Biotherapeutics

Nikolaos Tezapsidis

President & CEO Neurotez Inc.

Rick Ewing

VP, Head of Chemistry Rapafusyn Pharmaceuticals

Rick Ewing is VP, Head of Chemistry at Rapafusyn, a platform company focused on Type I molecular glues. Previous to Rapafusyn, Rick held the position of VP, Head of Drug Discovery at the Barer Institute. Prior to Barer, Rick was a senior director in Discovery Chemistry at Bristol Myers Squibb where he led medicinal chemistry teams to deliver 15 development candidates in the therapeutic areas of cardiovascular, diabetes, obesity, and heart failure. Among the development candidates is Milvexian, a first in class Factor XIa inhibitor currently in PIII 
development. Rick is coinventor on 79 patents, and co-author on 77 publications. In 2023, Rick was awarded the ACS Philadelphia Section Award for distinguished achievement in medicinal chemistry. In 2023, Rick also received the Edison Patent Award in Biotechnology Innovation with colleagues from BMS and Scripps Research. In 2021, he was awarded the ACS Fellow by the American 
Chemical Society and in 2018 received the Ondetti-Cushman award for leadership of the FXIa drug discovery team. Prior to Bristol Myers Squibb, Rick spent 12 years at RPR (now Sanofi). Rick received his Ph.D. in Organic Chemistry from U. Penn.

Robert Gabriel

Board Member, Managing Partner Ashur Capital

Sunil Joshi

President & CEO Protelis Bio

Our Agenda

Investment In Drug Discovery & Biotech
Drug Discovery Approaches towards Unlocking the Hard to Drug Proteome

Rick Ewing,
VP, Head of Chemistry,
Rapafusyn Pharmaceuticals

Investment In Drug Discovery & Biotech
Navigating Financial Risks and Rewards in Biotech: Investment Trends and Strategies for 2025
Allan Gobbs,
Co-Founder & Managing Partner,
ATEM Capital

Investment In Drug Discovery & Biotech
How Biotech Startups are Leveraging Investment for Growth and Innovation through Public and Private Funding Models

Heather Rose,
Vice President of Technology Licensing and Start-Ups,
Thomas Jefferson Health

Investment In Drug Discovery & Biotech
Navigating the Biotech Landscape: Strategic Investment Approaches in Drug Discovery for VCs and PE Firms

Investment In Drug Discovery & Biotech
Overcoming Investment Barriers in Biotech: R&D Costs, IP Issues, and Market Uncertainty

CHAIRPERSION: Nikolaos Tezapsidis,
President & CEO,
Neurotez, Inc.

PANELISTS:
Arnold Lippa,
Executive Chairman, Chief Executive Officer and Chief Scientific Officer,
RespireRx Pharmaceuticals Inc

Mark Tornetta,
VP/Director of Biologics Discovery,
Tavotek Biotherapeutics

Sunil Joshi,
President & CEO,
Protelis Bio

Investment In Clinical Trials
The Future of Clinical Trials and Investment

PRESENTER: Ashok Srivastava,
Chief Clinical Officer,
Autolus Therapeutics

Investment In Clinical Trials
Balancing Cost-Effectiveness with Data Reliability in Decentralized Models

Investment In Clinical Trials
Global Expansion of Clinical Trials: Opportunities and Challenges

Investment In Clinical Trials
Evaluating the Role of Strategic Partnerships in Mitigating Risks and Enhancing Funding or Expertise for Clinical Trials

Alex Zisson,
Managing Director,
H.I.G. Capital

Investment In Clinical Trials
Exploring the Key Strategies for Improving the Cost-Efficiency of Clinical Trials and Increasing ROI for Investors?

Robert Gabriel,
Board Member, Managing Partner,
Ashur Capital

Investment In Clinical Trials
Maximizing ROI in Clinical Trials: Navigating Risk, Innovation, and Opportunity

Register Now

As the event is hosted in person, attendance is limited. We want to make sure your experience with us is relevant. Therefore, we will confirm each registered guest individually. Please check your inbox for the confirmation email.

Choose Your Venture Date

*First name

*Last name

*Company name

*Job Title

*First line of address

*City

*Postcode/Zipcode

*Country

*Work Email

*Direct Line

*Mobile/Cell

*What are your 3 main strategic challenges?

***We Highly Recommend to Use Google Chrome, Safari or Firefox Browser.

I hereby consent Proventa International to collect and share my provided contact details to other delegates and sponsors attending the same event I am attending.

I agree to Proventa International using this information to contact me about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy.

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

Europe

USA East

USA West

Webinars

Europe

R&D

Investment Dinners & Spotlights

Venture Capital & Private Equity

Venture Capital & Private Equity

Investment Challenges and Opportunities in Emerging Biotech Markets

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2012%2016'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Hyatt Regency Princeton

Timely information, interactive format

Meet Our Facilitators

Alex Zisson

Allan Gobbs

Arnold Lippa

Ashok Srivastava

Heather Rose

Mark Tornetta

Nikolaos Tezapsidis

Rick Ewing

Robert Gabriel

Sunil Joshi

Our Agenda

Day 1 : 14th of May, 2025

Registration And Welcome

Opening Keynote Presentation

Roundtable Roundtable Tracks

Refreshment Break

Networking / 1-1 Meetings

Roundtable Roundtable Tracks

Networking Lunch

Networking / 1-1 Meetings

Roundtable Roundtable Tracks

Afternoon Refreshment Break

Panel Discussion

Drinks & Canapes Reception

Day 2 : 15th of May, 2025

Registration And Welcome

Opening Keynote Presentation

Roundtable Roundtable Tracks

Refreshment Break

Networking / 1-1 Meetings

Roundtable Roundtable Tracks

Roundtable Roundtable Tracks

Networking Lunch

Roundtable Roundtable Tracks

Afternoon Refreshment Break

Panel Discussion

Drinks & Canapes Reception

Register Now

You had been successfully registered.

Further Information

Here To Help

Select days you wish to attend You can add multiple days

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Rheumatology

Endocrinology

Nephrology

Hyatt Regency Princeton